Inge R F van Berlo-van de Laar (I R F van Berlo-van de Laar)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Ejection Fraction

Cardiovascular Disease

Prognostic Factors

Top Venues

International journal of clinical pharmacy

European journal of clinical pharmacology

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Inge R F van Berlo-van de Laar, Ilona Prins-Can, Aliesa A de Lange, Katja Taxis, Frank G A Jansman
Binding interactions with sevelamer and polystyrene sulfonate in vitro. Pharmacology research & perspectives 9 (4) (2022)
Inge R F van Berlo-van de Laar, I Prins-Can, C C M Schuiling-Veninga, K Taxis, F G A Jansman
Exploring co-dispensed drug use in patients on sevelamer or polystyrene sulfonate to identify potential novel binding interactions: a cross sectional in silico study : Potential novel binding interactions with resins. International journal of clinical pharmacy (2021)
Inge R F van Berlo-van de Laar, A Gedik, E van 't Riet, A de Meijer, K Taxis, F G A Jansman
Identifying patients with metformin associated lactic acidosis in the emergency department. International journal of clinical pharmacy 42 (5) (2020)
Inge R F van Berlo-van de Laar, Cornelis G Vermeij, Marjo van den Elsen-Hutten, Arthur de Meijer, Katja Taxis, Frank G A Jansman
Extracorporeal treatment of metforminassociated lactic acidosis in clinical practice: a retrospective cohort study. European journal of clinical pharmacology 76 (6) (2020)